Australian Cannabis Producer Little Green Pharma Reports Record Revenue, 80% Increase In European Sales QoQ
Portfolio Pulse from Nina Zdinjak
Little Green Pharma, an Australian cannabis producer, reported record revenue of AU$10.2 million for the quarter, with significant growth in European sales, particularly in France. The company anticipates further growth as European markets, like France, move towards legalizing medical marijuana.
October 21, 2024 | 2:00 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Little Green Pharma reported record quarterly revenue, driven by a 60% increase in European sales. The company is poised for further growth as France moves towards legalizing medical marijuana.
The record revenue and significant growth in European sales, especially in France, indicate strong market demand and potential for future growth. The anticipated legalization of medical marijuana in France could further boost sales, making this news highly relevant and positive for LPG's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100